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Abstract
Background: It is thought that a good survival rate of patients with acute liver failure can be achieved by establishing 
an artificial liver support system that reliably compensates liver function until the liver regenerates or a patient 
undergoes transplantation. We introduced a new artificial liver support system, on-line hemodiafiltration, in patients 
with acute liver failure.
Methods: This case series study was conducted from May 2001 to October 2008 at the medical intensive care unit of a 
tertiary care academic medical center. Seventeen consecutive patients who admitted to our hospital presenting with 
acute liver failure were treated with artificial liver support including daily on-line hemodiafiltration and plasma 
exchange.
Results: After 4.9 ± 0.7 (mean ± SD) on-line hemodiafiltration sessions, 16 of 17 (94.1%) patients completely recovered 
from hepatic encephalopathy and maintained consciousness for 16.4 ± 3.4 (7-55) days until discontinuation of artificial 
liver support (a total of 14.4 ± 2.6 [6-47] on-line hemodiafiltration sessions). Significant correlation was observed 
between the degree of encephalopathy and number of sessions of on-line HDF required for recovery of consciousness. 
Of the 16 patients who recovered consciousness, 7 fully recovered and returned to society with no cognitive sequelae, 
3 died of complications of acute liver failure except brain edema, and the remaining 6 were candidates for liver 
transplantation; 2 of them received living-related liver transplantation but 4 died without transplantation after 
discontinuation of therapy.
Conclusions: On-line hemodiafiltration was effective in patients with acute liver failure, and consciousness was 
maintained for the duration of artificial liver support, even in those in whom it was considered that hepatic function 
was completely abolished.
Background
Acute liver failure is usually fatal, and in the US, the mor-
tality rate remains as high as 30% in adult patients [1].
Although liver transplantation for acute liver failure has
increased the survival rate markedly, the limited supply of
suitable livers implies that transplantation is not available
to all patients; 22.7% of patients who were listed for trans-
plantation die awaiting transplantation 3 days after being
listed (range 1-6 days). On the other hand, 45% of
patients with acute liver failure survive with medical ther-
apy alone without liver transplantation [1]. It is thought
that a good survival rate can be achieved by establishing
an artificial liver support (ALS) system that reliably com-
pensates liver function until the liver regenerates or a
patient undergoes transplantation. Although various
attempts have been made to develop an ALS system,
there is no consensus about the best method [2,3].
A combination of hemodiafiltration (HDF) and plasma
exchange has been frequently used in patients with acute
liver failure in Japan, and this method results in improve-
ment of consciousness in 90% or more of cases [4]. How-
ever, HDF is complex and is not available in general
facilities. Moreover, there are economical problems, the
practical therapy is often shortened or limited in effi-
ciency because of the cost. Infusion-free HDF "on-line
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HDF," was developed with the purpose of solving these
problems [5]. On-line HDF markedly reduces the cost of
blood purification therapy and simplifies the setup of the
d i a l y s i s  m o n i t o r .  A  n u m b e r  o f  c l i n i c a l  b e n e f i t s  o f  t h i s
method in the treatment for chronic renal failure were
reported, especially the superior efficiency removing
middle molecules [6-12].
We introduced a new ALS system, on-line HDF, in
patients with acute liver failure. Here, we report our
experience in a substantial number of patients with acute
liver failure treated with this ALS system.
Methods
Patients
Between May 2001 and October 2008, 25 patients with
acute liver failure were treated at our hospital. Acute liver
failure was diagnosed by the presence of coagulopathy
(prothrombin time [PT] international normalized ratio
[INR] ≥1.5), any degree of hepatic encephalopathy, and
length of illness ≤24 weeks [1]. Acute liver failure was also
confirmed by the medical history, clinical findings, bio-
chemical test, viral serologies, and imaging methods. The
exclusion criteria for entry into the study were: 1) clinical
evidence of severe cerebral edema or cerebral herniation
at the time of admission, 2) no consent to on-line HDF by
patient or relatives, and 3) obvious improvement of con-
dition at the time of hospitalization. Eight patients with
acute liver failure admitted during the study period were
excluded from the analysis on the basis of these exclusion
criteria. Three patients presented deep coma, and severe
cerebral edema at the time of admission. All these 3
patients also presented multiple organ failure, and died 1,
2, and 4 days after admission, respectively. In a patient
who presented hypovolemic shock due to dehydration,
we could not obtain the consent because he did not have
relatives, and standard medical therapy improved his
consciousness promptly. In the remaining 4 patients who
presented acute liver failure due to congestion, the treat-
ment for congestive heart failure improved their condi-
tion with no need of ALS. Ultimately 17 patients were
included in this study. The characteristics of the partici-
pating patients (baseline clinical and laboratory data) are
summarized in Table 1. There were 11 men, aged 26-72
years (49.3 ± 4.3 years), and 6 women, aged 21-52 years
(40.7 ± 4.5 years). The etiology of acute liver failure was
hepatitis B virus infection in 10 patients, non-A~G hepa-
titis virus infection in 2 (indeterminate), alcoholic sus-
pected with the medical history in 2, congestive liver in 1,
infiltration of leukemia cells in 1, and acetaminophen
overdose in 1. In eight patients of 10 patients who suf-
fered from hepatitis B virus infection, the hepatitis B sur-
face antigen and an IgM antibody to the hepatitis B core
antigen were positive (acute infection). In the remaining 2
patients, the medical history that they had been healthy
carriers of hepatitis B virus was proven by their medical
records, and viral serologies on admission revealed acute
exacerbation of hepatitis B infection. Acute liver failure
developed in a patient of these 2 patients after the inter-
ruption of administration of steroids for multiple
myeloma. The average time from the onset of the disease
until admission to the hospital was 10.4 ± 3.3 days with a
range of 3-60 days. Eleven of the 17 patients had enceph-
alopathy on admission, and the remaining 6 had enceph-
alopathy 2.7 ± 0.9 days after admission with a range of 1-6
days.
These patients were initially treated with intensive
medical therapy, including immunosuppressive therapy,
antiviral therapy (lamivudine or entecavir for hepatitis B
virus infection), and the new ALS system comprising on-
line HDF and plasma exchange. At the time of the diag-
nosis of acute liver failure was made, the need for liver
transplantation was explained to the patient's relatives.
Hepatic encephalopathy was assessed using the West
Haven criteria of altered mental state [13] and the Glas-
gow Coma Scale in accordance with the recommendation
of a working party on studies in hepatic encephalopathy
[14]. Two investigators, who had extensive clinical experi-
ence in hepatic encephalopathy, confirmed all cases of
encephalopathy by reviewing the clinical course of the
patient during hospitalization. All patients underwent
computerized tomography (CT) examination to deter-
mine liver volume on admission and at least once a week
thereafter.
The study was performed according to the guidelines of
the Declaration of Helsinki and the study protocol was
approved by the ethics committee at our institution.
Written informed consent was obtained from each
patient or their relative if the patient was unable to give
consent.
Artificial liver support
On-line HDF
Blood access was established with a double-lumen cathe-
ter (Vas-Cath®, Niagara®; Bard, Salt Lake City, UT, USA)
inserted into a central vein with an internal jugular vein
approach. On-line HDF was performed as previously
described [15,16]. In brief, in the on-line solution prepa-
ration system, substitution fluid was prepared continu-
ously by ultrafiltration of dialysate, enabling its use as
substitution fluid. In our on-line system, two ultrafilters
(EF-01, FLX-18GW, polyester-polymer alloy [PEPA]
membranes; Nikkiso, Tokyo, Japan) were used for cold
sterilization of the dialysate (AK-Solita® FL; Ajinomoto
Pharma, Tokyo, Japan) in hemodialysis (HD), and one
ultrafilter (EF-01, FLX-18GW, PEPA; Nikkiso) was added
when using substitution fluid (Figure 1). Sterile substitu-
tion fluid produced on-line from the dialysate was
infused pre-filter with a substitution fluid pump and tub-A
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Table 1: Characteristics of participating patients who underwent artificial liver support with on-line hemodiafiltration.
Case Gender Age Etiology Onset-admission(days) Onset-encephalopathy (days) Highest AST (IU/L) Laboratory findings at the start of on-line HDF
AST (IU/L) TBil (mg/dL) PT (INR) ammnoia (μg/dL)
1 F 41 HBV acute infection 6 6 9280 1852 7.8 4.22 85
2 M 54 HBV carrier 17 19 6200 4470 5.6 4.52 116
3 M 53 HBV acute infection 4 5 6430 29 23.3 4.02 102
4 M 72 Congestive liver 5 5 11800 94 20.9 1.5 41
5 M 56 Leukemia 14 14 6584 6584 10 1.84 79
6 M 26 HBV acute infection 10 10 275 275 9 3.26 318
7 F 21 Indeterminate 3 3 25400 3295 7.4 3.45 107
8 M 48 HBV acute infection 6 7 11000 1690 4.7 2.79 157
9 F 36 Acetaminophen 4 4 5450 5450 4.6 12< 306
10 M 68 HBV acute infection 6 6 1259 187 6.6 2.06 294
11 M 43 Alcohol 3 9 20548 10570 4.5 2.15 253
12 M 40 HBV acute infection 5 6 8056 1023 11.5 2.44 223
13 M 53 HBV acute infection 7 6 8790 2765 9.3 2.65 246
14 M 29 HBV acute infection 5 5 902 678 16.1 12< 223
15 F 48 Indeterminate 60 65 227 88 6.4 2.95 155
16 F 46 Alcohol 9 8 84 81 15.8 1.6 302
17 F 52 HBV carrier 13 13 126 126 19.6 2.59 131
HBV, hepatitis B virus; HDF, hemodiafiltration; AST, asparatate aminotransferase; TBil, total bilirubin; PT, prothrombin time; Highest AST, Highest values that could be recorded during illness.Arata et al. BMC Emergency Medicine 2010, 10:10
http://www.biomedcentral.com/1471-227X/10/10
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ing set (PRS-12, NV-A300PA; Nikkiso) (pre-dilution).
HDF was performed using filters containing 1.5 m2 of
polysulfone membranes (APS-15E; Asahi Kasei Medical
Co., Tokyo, Japan). Pore size was 85 Å. A HD control
device and tubing set (model DBG-02, NV-Y888PC; Nik-
kiso) were used. An AK-Solita FL was set to prepare 700
mL/min of dialysate. Substitution fluid flow rates ranged
from 300 to 350 mL/min, so that actual dialysate flow
rates during HDF ranged from 350 to 400 mL/min. Blood
flow rates ranged from 300 to 350 mL/min. At the start,
the duration of on-line HDF was set so that the amount of
hemocatharsis (blood flow rate × time) was three times
the estimated body fluid volume (actual body weight
×0.6). If the patient recovered from encephalopathy and
disorientation disappeared, the duration of on-line HDF
was reduced to two-thirds of the initial duration, and if
consciousness was maintained under this condition, on-
line HDF was given once per 2 days.
Plasma exchange
In general, plasma exchange was performed using 40
packs of fresh frozen plasma per treatment. If PT-INR on
the day after previous plasma exchange was higher than
2.0, plasma exchange was performed with the same set-
ting. If PT-INR was less than 2.0, infusion of 8 packs of
fresh frozen plasma was performed in place of plasma
exchange. During infusion of fresh frozen plasma, we
reduced the quantity of the other infusion solution to
avoid fluid overloading.
Statistical Analysis
Data are expressed as mean ± SD. We performed simple
linear regression analysis to determine whether the
degree of encephalopathy (stage of hepatic encephalopa-
thy and Glasgow Coma Scale), patient's age, asparatate
aminotransferase, total bilirubin, PT, and ammonia at the
start of on-line HDF was associated with the number of
sessions of on-line HDF from the start of the treatment to
r e c o v e ry  o f  c o n s c i o u s n e s s.  W e  u s e d  s t u d e n t ' s  t-test to
compare between continuous data of patients who sur-
vived hepatic failure without transplantation and those of
patients who died of hepatic failure. All P values were
two-sided, and values less than 0.05 were considered sta-
tistically significant.
Results
Tolerance to on-line HDF was excellent, pyrogenic reac-
tions, bleeding complications, progress of coagulopathy
that the treatment related to were not observed. The con-
sciousness level, summary of ALS, and prognosis of par-
ticipating patients who underwent ALS with on-line HDF
are summarized in Table 2. At the start of the study, 2
patients had stage 2 encephalopathy, 7 had stage 3, and 8
had stage 4. During ALS with on-line HDF, 1 patient
(Case 6) withdrew from the further investigation. He suf-
fered from brain herniation with rapid progression of
cerebral edema on the first day of admission and fell into
deep coma. A flat wave was confirmed by electroenceph-
alography performed on the second day. The prolonga-
tion of the treatment was thought to be not worthwhile.
ALS was discontinued after we obtained his family's con-
sent. He died on the 5th day of hospitalization. However,
all the remaining 16 patients recovered consciousness
after ALS with on-line HDF, and the average number of
sessions of on-line HDF from the start of the treatment to
recovery of the patient's consciousness was 4.9 ± 0.7 with
a range of 1-10. The average total number of sessions of
on-line HDF was 14.4 ± 2.6 with a range of 6-47 over a
period of 7-55 days (mean 16.4 ± 3.4 days). During ALS
with on-line HDF, plasma exchange was performed in 11
patients with a range of 2-17 sessions (mean 7.2 ± 1.3 ses-
sions).
Of the 16 patients who recovered consciousness, 7
recovered without transplantation (spontaneous survival)
and 3 died of congestive heart failure, sepsis, or respira-
tory failure. Two underwent living-related liver trans-
plantation. The remaining 4 patients were candidates for
liver transplantation, but these 4 patients died without
transplantation because of the lack of a living donor can-
didate. In patients who were candidates for transplanta-
tion but died without it, on-line HDF was performed in
11-27 sessions (mean, 16.8 ± 3.5 sessions) and plasma
exchange was performed in all patients, with 9-17 ses-
sions (mean 11.3 ± 1.9 sessions) over a period of 13-42
days (mean 21.0 ± 7.0 days). During ALS with on-line
HDF, these patients showed clear consciousness; how-
ever, they died of severe hepatic failure 2-4 days after the
termination of intensive medical care. Final liver vol-
umes, estimated by CT or proven by autopsy, ranged
from 332 to 467 mL (mean 375.0 ± 31.5 mL). Autopsy
Figure 1 The circuit of on-line hemodiafiltration with pre dilu-
tion. Sterile substitution fluid produced on-line from the dialysate 
through three ultrafilters. Substitution fluid was infused pre-filter with 
a substitution fluid pump. HD, hemodialysis.A
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Table 2: The consciousness level, summary of ALS, and outcome of participating patients who underwent artificial liver support with on-line hemodiafiltration.
Case The degree of HE at the start of 
on-line HDF
On-line HDF to recovery of 
consciousness (sessions)
Total on-line HDF 
(sessions)
Plasma exchange 
(sessions)
Duration of ALS 
(days)
Outcome
GCS Stage*
18 4 5 1 2 7 1 3 S p o n t a n e o u s  s u r v i v a l
2 13 3 2 11 9 13 Death (no donor to transplant)
3 13 2 1 15 10 15 Death (no donor to transplant)
4 9 4 7 7 0 7 Death due to heart failure
51 1 3 4 1 5 0 1 5 D e a t h  d u e  t o  s e p s i s
6 4 4 - 5 4 5 Death due to cerebral herniation
71 2 4 5 8 2 1 0 S p o n t a n e o u s  s u r v i v a l
8 13 3 8 47 5 55 Spontaneous survival
9 10 4 7 21 8 24 Death from respiratory failure
10 6 4 7 14 9 14 Death (no donor to transplant)
11 14 2 1 9 2 9 Spontaneous survival
12 13 3 1 13 2 13 Spontaneous survival
13 13 3 5 7 0 7 Spontaneous survival
14 6 4 10 27 17 42 Death (no donor to transplant)
15 12 3 5 7 0 7 Transplantation
16 4 4 5 6 0 7 Spontaneous survival
17 8 3 6 11 8 12 Transplantation
HE, hepatic encephalopathy; HDF, hemodiafiltration; GCS, Glasgow Coma Scale; ALS, artificial liver support. *Hepatic encephalopathy staging by the West Haven criteria of altered mental state [13].Arata et al. BMC Emergency Medicine 2010, 10:10
http://www.biomedcentral.com/1471-227X/10/10
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specimens from 1 patient revealed no sign of regenera-
tion of the liver pathologically.
Figure 2 shows the changes of serum bilirubin and
ammonia levels during first ten days after the start of ALS
dividing it into two groups of the 7 patients with sponta-
neous survival and the 4 patients who died of liver failure.
The serum bilirubin levels increased gradually in both
groups, whereas the serum ammonia levels of the
patients with spontaneous survival decreased to less than
100 μg/dL on the 7th day after the start of the treatment
with a constant tendency.
Significant correlation was observed between the
degree of encephalopathy (stage of hepatic encephalopa-
thy and Glasgow Coma Scale) at the start of on-line HDF
and the number of sessions of on-line HDF from the start
of the treatment to recovery of consciousness (Figure 3).
However, no significant correlation was observed
between the number of sessions of on-line HDF from the
start of the treatment to recovery of consciousness and
the following parameters: patient's age, asparatate amin-
otransferase, total bilirubin, PT, and ammonia at the start
of on-line HDF. There were also no significant differences
between 7 patients who survived hepatic failure without
transplantation and 4 patients who died of hepatic failure
with respect to the average time from disease onset to
hospital admission, and the number of sessions of on-line
HDF from the start of the treatment to recovery of con-
sciousness.
Case presentation
Case 14
Five weeks after completion of a tattoo procedure on his
back, a 29-year-old Japanese man was transferred to our
hospital for treatment of acute liver failure due to acute
hepatitis B virus infection. At admission, his conscious-
ness level represented stage 4 encephalopathy (Glasgow
Coma Scale E1V1M4). Liver volume estimated by CT was
650 mL. Figure 4 depicts the clinical course after the start
o f  o n - l i n e  H D F .  H e  b e c a m e  r e s p o n s i v e  t o  c a l l i n g  a n d
completely recovered from encephalopathy after 10 daily
sessions of on-line HDF. On the 13th hospital day, oral
intake was started and his consciousness remained clear
with the scheduled on-line HDF. CT examination
revealed further progression of liver atrophy and liver
transplantation was therefore recommended to the
patient and his relatives; however, the relatives refused.
He died on the 42nd hospital day from severe hepatic fail-
ure; however, his consciousness remained clear until dis-
continuation of ALS with on-line HDF. Autopsy 19 h after
death revealed a liver weight of 332 g and the absence of
viable hepatocytes (Figure 5).
Case 17
A 52-year-old Chinese woman had been diagnosed as a
healthy carrier of Hepatitis B Virus at the time of previous
orthopedic treatment. Her illness began with general
fatigue and appetite loss on the day before hospital
admission. Acute liver failure was diagnosed and she was
started on steroid injections, entecavir, and fresh frozen
plasma supplementation for 12 days, but disturbance of
Figure 2 The changes of the serum bilirubin and ammonia levels during first ten days after the start of artificial liver support. The solid line 
and dashed line shows the values of the patients who survived hepatic failure without transplantation (Case 1, 7, 8, 11-13, 16) and the patients who 
died of liver failure (Case 2, 3, 10, 14), respectively. The serum bilirubin levels increased gradually in almost patients of both groups (A). The serum am-
monia levels of the patients who survived hepatic failure without transplantation decreased to less than 100 μg/dL on the 7th day after the start of 
the treatment with a constant tendency (B).Arata et al. BMC Emergency Medicine 2010, 10:10
http://www.biomedcentral.com/1471-227X/10/10
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consciousness appeared and she was transferred to our
hospital. At admission, her consciousness level repre-
sented stage 3 encephalopathy (Glasgow Coma Scale
E2V2M4). CT examination revealed marked liver atro-
phy. Daily on-line HDF and PE were promptly started.
She completely recovered from encephalopathy after six
daily sessions of on-line HDF. Her consciousness
remained clear with daily on-line HDF. On the 10th hos-
pital day, CT revealed no sign of liver regeneration, and
the estimated liver volume was 592 mL. Liver transplan-
tation was performed and the weight of her extracted
liver was 700 g.
Discussion
We introduced ALS using on-line HDF with plasma
exchange for patients with acute liver failure. In our expe-
rience, all patients, except one died of cerebral herniation
with rapid progression of severe cerebral edema on the
first day of admission, recovered consciousness after 4.9
± 0.7 sessions of on-line HDF. Furthermore, conscious-
ness remained clear after initial improvement by ALS
with on-line HDF over a period of 16.4 ± 3.4 days until
discontinuation of treatment.
Unusual accumulation of agents acting on the central
nervous system requiring the liver to deal with toxic sub-
stances was the main mechanism of consciousness disor-
der caused by liver failure [17]. Ammonia, a key toxin in
these substances [18], is related to brain edema and may
lead to cerebral herniation, which is a major cause of
death in patients with acute liver failure. An arterial
blood ammonia concentration above 200 μg/dL con-
ferred a high risk of cerebral herniation [19]. On the other
hand, our experience is that serum ammonia concentra-
tion does not correlate with the degree of hepatic enceph-
alopathy in patients with acute liver failure occasionally.
It was shown that HD was insufficient for the treatment
of hepatic encephalopathy [20], although it could remove
ammonia, a small molecule [21-23]. At present, it is pro-
posed as one opinion that the causal agents of hepatic
encephalopathy are presumed to be middle molecules
[24]. Blood purification therapy for patients with acute
liver failure aims to remove ammonia, which can cause a
critical situation with brain edema, and middle molecules
have a high potential for central nervous system toxicity.
Splendiani et al. [20] reported improvement of con-
sciousness in 37.5% of patients with acute liver failure
who were treated with plasmapheresis. Therefore, plasma
exchange alone is clearly insufficient for maintaining alert
wakefulness in patients with severe hepatic encephalopa-
thy. Improvement of consciousness in patients with
hepatic encephalopathy was reported in 40% of those
treated with HD and 78% of those receiving hemofiltra-
tion (HF) [20]. HD is effective in removing substances of
small molecular weight but cannot provide efficient
removal of substances of middle molecular weight. HF is
effective in removing middle molecular weight sub-
stances but cannot remove small molecules effectively
[25]. To compensate for these disadvantages, HDF is
widely acknowledged today as a means of removing both
small and middle molecular weight substances in renal
replacement therapy [26-28].
Figure 3 Correlation between the degree of encephalopathy and the number of sessions of on-line hemodiafiltration to recovery of con-
sciousness. Significant correlation was observed between (A) stage of hepatic encephalopathy [13] and (B) Glasgow Coma Scale at the start of on-
line hemodiafiltration and the number of sessions of on-line hemodiafiltration from the start of the treatment to recovery of consciousness. HDF, he-
modiafiltration.Arata et al. BMC Emergency Medicine 2010, 10:10
http://www.biomedcentral.com/1471-227X/10/10
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In HDF, there are costs and storage problems because
of the large amount of sterile substitution fluid required,
which is usually supplied in ready-to-use bags. Further-
more, there is the need to connect multiple bags and tub-
ing segments, the circuit is relatively complicated, and the
risk of blood contamination may be high. For these rea-
sons, HDF has not been applied routinely in the treat-
ment of chronic renal failure, and is not commonly
available in general facilities for the treatment of acute
liver failure.
The new technique of on-line HDF is superior to con-
ventional HDF and reduces the cost and simplifies the
procedure [5]. On-line HDF can supply an unlimited
amount of substitution fluid because the dialysate is pre-
pared using an on-line system. Previous studies which
described efficacy of hemodiabsorption or hemofiltration
also reported some beneficial effects on hepatic enceph-
alopachy, but failed to demonstrate sufficient improve-
ment of hepatic encephalopathy [20,29,30]. Our ALS is
much different from these studies at the point of amount
of substitution fluid. Compared with HD, the only addi-
tional costs are those of the minute particle filter and the
cost of controlling water quality. This system reduces the
cost of substitution fluid and simplifies the setup of the
dialysis monitor. Studies comparing it with high-flux HD
reported its safety and superiority in the efficiency of
removing middle molecules [6,7]. Furthermore, clinical
findings of improved cardiovascular stability [8,9],
reduced erythropoietin requirements [10,11], and
improved immune response [12] with on-line HDF were
reported. These were considered to be due to the removal
of middle molecules with cardiodepressive effects, inhibi-
tory effects on erythropoiesis, or depressive effects on the
immune system.
The purification of the supplied water and the control
of line cleaning make it possible to give the patient
dialysate as a substitution fluid. The 1994 water quality
standard in Japan entailed an obligation to use at least
Figure 4 Clinical course after the start of artificial liver support with on-line hemodiafiltration. After 10 on-line hemodiafiltration sessions, a 29-
year-old man with acute hepatitis B virus infection (Case 14) experienced complete and rapid resolution of hepatic encephalopathy. Artificial liver sup-
port with on-line hemodiafiltration and plasma exchange maintained lucid consciousness and minimal coagulation function for 25 days during an 
aggressive treatment period. Prothronbin time deteriorated without the plasma exchange rapidly and it could not be maintained by 8 units drip in-
fusion of fresh frozen plasma. Computerized tomography examination on 16th day revealed further progression of liver atrophy, liver transplantation 
was therefore recommended but he could not receive liver transplantation because of the lack of a living donor candidate. Then, the treatment was 
reduced, and discontinued on the 36th day. He died on the 42nd day. PE, plasma exchange; FFP, fresh frozen plasma; HDF, hemodiafiltration.Arata et al. BMC Emergency Medicine 2010, 10:10
http://www.biomedcentral.com/1471-227X/10/10
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two ultrafilters after the dialysate adjustment device for
cold sterilization. In studies of on-line HDF, the quality of
the dialysate after the first ultrafilter met European Phar-
macopoeia and US Pharmacopoeia standards for large-
volume substitution fluid, i.e., no detectable bacteria and
an endotoxin concentration below 0.25 IU/mL [31], and
the microbiological quality of the dialysate after second
ultrafilter was not different from that of autoclaved iso-
tonic saline solution [32].
Infusion of hypertonic saline to maintain serum sodium
levels of 145-155 mEq/L reduced the incidence and sever-
ity of intracranial hypertension in patients with grade 3 or
4 hepatic encephalopathy [33]. Like reducing ammonia,
the correction of hyponatremia, a common electrolyte
disorder in acute liver failure, is important for the avoid-
ance of the early death due to brain herniation. Use of an
on-line HDF system made it possible to vary the compo-
sition of dialysate individually by choosing different con-
centrates of electrolytes and machine settings. In this
study we adjusted the sodium concentration of dialysate
to 142-154 mEq/L to maintain the serum sodium level at
142 mEq/L or more. Only one of the study patients pro-
gressed to brain herniation during treatment.
Figure 6 shows the changes of the serum bilirubin and
ammonia levels in 5 patients who were excluded from the
study because of improvement with no need of ALS. The
serum bilirubin levels increased in some patients even
during the good clinical course, whereas the serum
ammonia levels decreased rapidly. Figure 2 and 6 sug-
gested that the change of serum ammonia levels may be a
more useful predictor of survival compared with that of
serum bilirubin levels.
In the present study, a significant correlation was
observed between the degree of encephalopathy at the
start of on-line HDF and the number of sessions of on-
line HDF from the start of the treatment to recovery of
consciousness. The degree of encephalopathy at the start
of on-line HDF may predict the number of sessions of on-
line HDF needed for recovery of consciousness. Patients
with severe hepatic encephalopathy at the start of on-line
HDF may need more than 10 sessions of on-line HDF to
recover . On the other hand, if pa tients with low grade
hepatic encephalopathy do not recover consciousness
after five or more sessions of on-line HDF, brain CT
should be performed to evaluate edema or hemorrhage.
The excellent clearance of various molecular sub-
stances with on-line HDF results in a number of clinical
benefits in treatment for chronic renal failure [8-12] and
is probably also of value in patients with acute hepatic
failure. On the other hand, efficiency of clearance often
conflicts with selectivity. In a small series of observations,
we found that albumin was removed at the rate of 3.9-8.8
g per on-line HDF session, necessitating compensation
for the loss of albumin with appropriate plasma exchange.
Furthermore, on-line HDF may remove unknown factors
that promote liver regeneration. It is still controversial
whether ALS may retard the rate of regeneration [34]. An
appropriate frequency of on-line HDF should be chosen
for patients with acute liver failure.
In meta-analysis of artificial and bioartificial support
system for the acute liver failure fails to reduce mortality,
but it shows some improvement of hepatic encephalopa-
thy in comparison with the standard medical therapy
[35]. In more recent randomized controlled trials, Hassa-
nein et al reported that 5 days treatment with extracorpo-
real albumin dialysis using molecular adsorbent
recirculating system is effective in 62% of cirrhotic
patients with severe hepatic encephalopathy [36]. This
system thought to be one of hopeful methods. However,
40% of the patients who treated with the standard medi-
cal therapy alone also improved their hepatic encephal-
opathy by 2 grades from baseline, and 34% of the patients
whose hepatic encephalopathy did not respond to the any
treatment survived after 2 weeks. There is a possibility
t h a t  t h e i r  e x p e r i e n c e  c a n n o t  b e  j u s t  a p p l i e d  t o  t h e
patients with acute liver failure. Our study was not con-
trolled study and study population was small. A larger
and randomized controlled trial is needed to confirm that
our experience can be generalized.
Conclusions
ALS with on-line HDF was effective in patients with
acute liver failure; in our experience of 16 patients, the
patient's consciousness could be maintained as long as
the duration of ALS even in conditions in which hepatic
function was considered to be completely abolished.
Figure 5 Photomicrograph of histopathological specimen. Histo-
pathological specimen (hematoxylin and eosin staining) obtained 
from case 14 revealed absence of hepatocytes and destruction of nor-
mal structure and inflammatory cell infiltration. Portal venous areas are 
close each other and hyperplasia of the small bile ducts is seen.Arata et al. BMC Emergency Medicine 2010, 10:10
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Although further investigation is necessary to clarify
whether the new ALS system improves the rate of sponta-
neous survival, this system may provide sufficient time to
prepare for transplantation in patients with acute liver
failure.
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